PharmEng Technology
1Tw Alexander Dr
Durham
NC
27703
United States
Tel: 855-937-2497
Website: https://pharmeng.com/about-us/
Email: nidhi.y@pharmeng.com
About PharmEng Technology
PharmEng Technology has been providing quality services to the Life Science Industry since 1997. Our specialists hold expertise in Commissioning & Qualification, Validation, Quality Systems, Regulatory Affairs, Engineering, and Training to ensure that our clients can keep on providing the world with their cost-effective and high-standard healthcare products. We provide a wide range of services to the pharmaceutical, biotechnology, medical device, and nutraceutical industries.
Our qualified and dedicated team focuses on providing quality services to our clients around the globe that is in line with industry standards. Quality is the most important part of our company’s value system. Our international presence ensures we are current with regulatory practices and ahead of the emerging trends around the globe. The diverse skill set of our professionals makes sure that every aspect of your needs are met with the highest precision.
Our staff brings a variety of disciplines to the table, to ensure every aspect of your project needs are met. PharmEng Technology is a multicultural company with staff all over the world servicing companies of all sizes. We are confident that we are the solution you need to operate in this highly regulated industry.
44 articles about PharmEng Technology
-
PharmEng Announces Opening Of Montreal Office
4/12/2017
-
PharmEng Announces Opening Of Denver Colorado Office
4/20/2016
-
PharmEng Obtained Court Approval for the Sale of the Consulting Business Assets
7/29/2009
-
PharmEng: Sales Process Initiated for the Assets of PharmEng International Inc., Keata Pharma Inc. and PharmEng Technology Inc.
5/15/2009
-
PharmEng Unable to File Its 2008 Audited Annual Financial Statements and Closes Sydney Manufacturing Facility
4/23/2009
-
PharmEng has Received Notice of Reclassification to Tier 2 Issuer Status
4/21/2009
-
PharmEng has Received Notice of Reclassification to Tier 2 Issuer Status
4/21/2009
-
PharmEng Has Filed Notice of Intention to Make a Proposal Under the Bankruptcy & Insolvency Act (Canada)
4/15/2009
-
PharmEng Announces Resignation of Director
4/14/2009
-
PharmEng Announces Corporate Changes; CEO Takes 50% Salary Reduction
4/13/2009
-
PharmEng to Receive Government Financial Support for Research Into Treatment for Alzheimer's Disease
2/2/2009
-
PharmEng Announces New Supply Agreement With Multi-National Consumer Healthcare Company
1/6/2009
-
PharmEng Announces Organizational Restructuring
12/11/2008
-
PharmEng Reports Reduced Cash Burn, Financing Update, Strategic Update, Board Member Additions, and Third Quarter Earnings for 2008
12/1/2008
-
PharmEng Board Changes
11/7/2008
-
PharmEng CFO Change Announcement
10/6/2008
-
PharmEng Reports Second Quarter Earnings for 2008
8/29/2008
-
PharmEng Receives Site License From Health Canada To Manufacture Natural Health Products In Sydney, Nova Scotia
7/18/2008
-
PharmEng Receives Establishment License From Health Canada for New Facility in Sydney, Nova Scotia
7/8/2008
-
PharmEng Relocates Perth, Ontario Pharmaceutical Contract Manufacturing Operations to New Facility in Sydney, Nova Scotia
6/17/2008